EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $21.53, but opened at $20.26. EyePoint Pharmaceuticals shares last traded at $20.84, with a volume of 50,221 shares changing hands. Analyst Ratings Changes Several research analysts recently commented on the company. Mizuho […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been assigned a consensus rating of “Buy” from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokers that have issued ratings on the stock […]
EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) issued its earnings results on Thursday. The company reported ($0.33) EPS for the quarter, topping the consensus estimate of ($0.60) by $0.27, Zacks reports. The firm had revenue of $14.03 million during the quarter, compared to the consensus estimate of $8.71 million. EyePoint Pharmaceuticals had a negative return […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been assigned an average rating of “Buy” from the seven ratings firms that are covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy rating. The average 12 month price objective among analysts that have covered the stock in the last […]
Investment analysts at JPMorgan Chase & Co. assumed coverage on shares of EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) in a report issued on Monday, MarketBeat reports. The firm set an “overweight” rating and a $35.00 price target on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 40.51% from the […]